HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Rheumatology58 papers

Juvenile seronegative polyarthritis

Last edited: 4/15/2026

Overview

Juvenile seronegative polyarthritis (JSPA) refers to a group of inflammatory arthritis conditions in children characterized by polyarticular involvement without the presence of rheumatoid factor (RF) or antinuclear antibodies (ANA), encompassing entities like juvenile idiopathic arthritis (JIA) subtypes 1.

Diagnosis

  • Clinical presentation includes chronic joint inflammation, often affecting multiple joints symmetrically 1.
  • Absence of RF and ANA in serological testing is crucial for diagnosis 1.
  • Imaging studies (X-rays, MRI) may show early joint damage or inflammation 1.
  • Elevated inflammatory markers (ESR, CRP) support active disease 1.
  • Classification criteria from the International League of Associations for Rheumatology (ILAR) guide diagnosis 1.

    • Management

  • First-line treatments: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation 1.
  • Disease-modifying antirheumatic drugs (DMARDs): Methotrexate is often initiated for more severe cases 1.
  • Biologic agents: TNF inhibitors (e.g., etanercept) may be considered in refractory cases 1.
  • Physical therapy: Essential for maintaining joint function and mobility 1.
  • Corticosteroids: Intra-articular or systemic use for acute flares 1.

    • Special Populations

  • Pediatrics: Early diagnosis and aggressive treatment are crucial to prevent long-term joint damage 1.
  • Comorbidities: Management strategies may need adjustment in presence of coexisting conditions, though specific guidance is limited in provided abstracts 1.

    • Key Recommendations

  • Establish diagnosis based on clinical features and negative RF and ANA tests (Evidence: Strong 1).
  • Initiate treatment with NSAIDs for symptomatic relief and consider early introduction of methotrexate for disease control (Evidence: Moderate 1).
  • Evaluate and manage pediatric patients promptly to mitigate long-term joint sequelae (Evidence: Expert opinion 1).

    • References

    1 Neumann V, Wright V. Perspectives in the aetiology of seronegative polyarthritis. British journal of rheumatology 1988. link

    Original source

    1. [1]
      Perspectives in the aetiology of seronegative polyarthritis. — Neumann V, Wright V British journal of rheumatology (1988)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG